Literature DB >> 27884230

The Kidney in Hypertension.

Hillel Sternlicht1, George L Bakris2.   

Abstract

Hypertension is the second most common cause of chronic kidney disease (CKD) and is a potentiator of kidney failure when accompanying disease. CKD is a common cause of resistant hypertension. Nephropathy progression has dramatically slowed over the past 3 decades from an average of 8 to between 2-3 mL/min per year regardless of diabetes status. The incidence of very high albuminuria as well as progression from high albuminuria very high albuminuria has substantially decreased over the past 3 decades. This improvement relates to better blood pressure control using agents that slow nephropathy as well as better glycemic and cholesterol control. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetes; Hypertension; Kidney; Outcomes; Renal

Mesh:

Substances:

Year:  2017        PMID: 27884230     DOI: 10.1016/j.mcna.2016.08.001

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  10 in total

Review 1.  A Review of Noninvasive Methodologies to Estimate the Blood Pressure Waveform.

Authors:  Tasbiraha Athaya; Sunwoong Choi
Journal:  Sensors (Basel)       Date:  2022-05-23       Impact factor: 3.847

2.  Evolution of the stage of chronic kidney disease from the diagnosis of hypertension in primary care.

Authors:  Juan Figueroa-García; Víctor Granados-García; Juan Carlos H Hernández-Rivera; Montserrat Lagunes-Cisneros; Teresa Alvarado-Gutiérrez; José Ramón Paniagua-Sierra
Journal:  Aten Primaria       Date:  2022-05-13       Impact factor: 2.206

3.  Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.

Authors:  George L Bakris; Rajiv Agarwal; Stefan D Anker; Bertram Pitt; Luis M Ruilope; Christina Nowack; Peter Kolkhof; Anna C Ferreira; Patrick Schloemer; Gerasimos Filippatos
Journal:  Am J Nephrol       Date:  2019-10-25       Impact factor: 3.754

4.  Long-term efficacy and tolerability of azilsartan medoxomil/chlorthalidone vs olmesartan medoxomil/hydrochlorothiazide in chronic kidney disease.

Authors:  George L Bakris; Lin Zhao; Stuart Kupfer; Attila Juhasz; Michie Hisada; Eric Lloyd; Suzanne Oparil
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-03-04       Impact factor: 3.738

5.  Circulating antithyroid antibodies contribute to the decrease of glomerular filtration rate in lithium-treated patients: a longitudinal study.

Authors:  Alberto Bocchetta; Luca Ambrosiani; Gioia Baggiani; Claudia Pisanu; Caterina Chillotti; Raffaella Ardau; Fernanda Velluzzi; Doloretta Piras; Andrea Loviselli; Antonello Pani
Journal:  Int J Bipolar Disord       Date:  2018-03-01

6.  Senescent Kidney Cells in Hypertensive Patients Release Urinary Extracellular Vesicles.

Authors:  Adrian Santelli; In O Sun; Alfonso Eirin; Abdelrhman M Abumoawad; John R Woollard; Amir Lerman; Stephen C Textor; Amrutesh S Puranik; Lilach O Lerman
Journal:  J Am Heart Assoc       Date:  2019-06-01       Impact factor: 5.501

7.  Involvement of Muscarinic Receptors in Hypotensive and Diuretic Effects of Aqueous Soluble Fraction from Asphodelus tenuifolius Cav.

Authors:  Waqas Younis; V B Schini-Kerth; Samara Requena Nocchi; Denise Brentan Silva; Priscila de Souza; Ishfaq Ali Bukhari; Fahim Vohra; Sibtain Afzal; Arquimedes Gasparotto Junior
Journal:  Evid Based Complement Alternat Med       Date:  2021-01-15       Impact factor: 2.629

8.  Canonical Wnt signaling in the kidney in different hypertension models.

Authors:  Irena Kasacka; Zaneta Piotrowska; Natalia Domian; Magdalena Acewicz; Alicja Lewandowska
Journal:  Hypertens Res       Date:  2021-07-05       Impact factor: 3.872

9.  Hypertension and the Kidney: Reduced Kidney Mass Is Bad for Both Normotensive and Hypertensive Rats.

Authors:  Kyle Ware; Vedat Yildiz; Min Xiao; Ajay Medipally; Jessica Hemminger; Rachel Scarl; Anjali A Satoskar; Lee Hebert; Iouri Ivanov; Laura Biederman; Sergey V Brodsky
Journal:  Am J Hypertens       Date:  2021-11-20       Impact factor: 3.080

10.  Neonatal nephron loss during active nephrogenesis - detrimental impact with long-term renal consequences.

Authors:  Carlos Menendez-Castro; Dörte Nitz; Nada Cordasic; Jutta Jordan; Tobias Bäuerle; Fabian B Fahlbusch; Wolfgang Rascher; Karl F Hilgers; Andrea Hartner
Journal:  Sci Rep       Date:  2018-03-14       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.